The London School of Hygiene & Tropical Medicine (LSHTM) is renowned for its research, postgraduate studies, and continuing education in public and global health. Our mission is to improve health and health equity in the UK and worldwide; working in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice.
We have an international presence and collaborative ethos and draw on our diverse talents, skills and experience, to underpin our position as a leader in public and global health. These range from the molecular to the global, the theoretical to the applied, the analytical to the political. Innovative inter-disciplinary, cross-faculty research collaborations are fostered through a network of research groups and centres including the MARCH centre for Maternal, Adolescent, Reproductive and Child Health and the Antimicrobial Resistance Centre and the International Diagnostics Centre.
We perform strongly in various global university league tables. In the 2019 CWTS Leiden Ranking LSHTM is ranked the UK’s top university for the proportion of academic research with women listed as authors, first in Europe for publishing open access research, and 1st in Europe and 8th in the world for research impact in sciences (for the proportion of its total publications ranking in the top 10% of most cited research).
Led by Dr Shunmay Yeung, LSHTM is responsible for 2 work packages: the Comparative Health Service Evaluation & Cost Effectiveness Analysis (WP7) the Information Synthesis & Market Assessment (WP9). These work packages focus on the translational aspects of the DIAMONDS research programme with an aim of optimising the potential impact of new diagnostic tools in improving and personalising the management of febrile illness.
Taking advantage of LSHTM’s strength in interdisciplinary research, we draw on a broad range of skills including health economics, social science, modelling and clinical research. We work very closely with the other work packages to collect relevant clinical and technical data and gather, critically analyse and synthesise contextual, economic, social, and behavioural information to inform the development, implementation and evaluation of the new approach. Key activities will include qualitative and quantitative studies including interviews with clinicians, patients and key stakeholders, contributing to the pilot evaluation and cost-effectiveness modelling.
See all Partners
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 848196